Previous 10 | Next 10 |
SAN DIEGO, July 07, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and CEO, will be participating in a virtual panel discussion presented by Maxim Group LLC a...
Women health firm Daré Bioscience ( NASDAQ: DARE ) announced an exclusive license agreement with clinical-stage biopharma firm Organon ( NYSE: OGN ) to commercialize Xaciato, DARE's treatment of bacterial vaginosis in patients 12 years of age and older. U...
Daré will receive a $10 million upfront payment from Organon An estimated 21 million American women experience bacterial vaginosis SAN DIEGO, June 30, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Friday’s overturning of Roe vs. Wade has thrust contraceptive producer Evofem Biosciences (NASDAQ: EVFM ) into the spotlight. EVFM stock is skyrocketing as contraception makers come into focus. Evofem Bioscie...
Axsome Therapeutics (AXSM) +50%as FDA issues proposed labeling for depression drug. Agile Therapeutics (AGRX) +42%. Nutex Health (NUTX) +14%announces that it has been selected to join both the RUSSELL 2000® AND RUSSELL 3000® INDEXES. Femasys (FEMY) +16%. Siyata Mobile (SYTA) +1...
SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced partial adjournment of its 2022 Annual Meeting of Stockholders (the “Annual Meeting”) and voting results on all but one of...
H.C. Wainwright has downgraded TherapeuticsMD to neutral from buy following its recent agreement to be acquired by private equity firm EW Healthcare Partners. Analyst Douglas Tsao noted that the acquisition price represents ~367% premium to TherapeuticsMD's (NASDAQ:TXMD) closing price on May ...
SAN DIEGO, June 06, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will participate in a panel discussion and deliver a company ...
3 Good Penny Stocks to Watch in June 2022 Picking the best penny stocks to buy can be a tricky prospect. But, because there are so many options to choose from, investors can work to find penny stocks that are worth buying. Right now, we have to consider what is going on in the stock...
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, the company’s President and CEO, will participate in a virtual fireside chat during the H.C. Wainwr...
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 09:02:05 ET Dare Bioscience Inc (DARE) announced stock split at a ratio of 1-for-12 on 2024-07-01 ... Full story available on KlickAnalytics.com
Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024 SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced that it will implement a 1-for-12 reverse split...
Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with or without concomitant decreased desire There are currently no FDA-approved therapies fo...